20 May, 2017
For passive investors (long-term) earnings per shares and its growth is most valuable indicator for investment, as NEOG has EPS growth of 7.80% for this year while, JNJ standing at 8.30%. 1st Global Advisors Inc. raised its stake in Johnson & Johnson by 3.8% in the third quarter. Kanaly Tru holds 14,359 shares or 0.35% of its portfolio. Roffman Miller Pa, a Pennsylvania-based fund reported 190,263 shares. Karpas Strategies Limited Liability Corp holds 138,970 shares or 7.55% of its portfolio. Analysts are forecasting earnings of $1.78 on a per share basis this quarter. Fulton Bank & Trust Na reported 77,428 shares. 339,332 are owned by Alps Advsr Inc. Osterweis Capital Mngmt holds 2.29% or 275,764 shares. The Company's range of products includes intelligent mobile hotspots, universal serial bus modems, embedded modules, integrated asset-management and mobile tracking machine-to-machine (M2M) devices, communications and applications software and cloud services.
The share price of Johnson & Johnson (NYSE:JNJ) was up +0.24% during the last trading session, with a day high of 127.87. Stockholders of record on Tuesday, May 30th will be issued a dividend of $0.84 per share. Compass Capital Management Inc owns 181,081 shares for 3.89% of their portfolio. Burgundy Asset Management Ltd reported 3.64% of its portfolio in Johnson & Johnson (NYSE:JNJ). Moreover, Rand Wealth Lc has 1.95% invested in Johnson & Johnson (NYSE:JNJ). Therefore 47% are positive. Analysts expect that Johnson & Johnson will post $7.10 earnings per share for the current fiscal year. Argus Research upgraded Johnson & Johnson (NYSE:JNJ) on Wednesday, July 20 to "Buy" rating. The New York-based Grandfield And Dodd Llc has invested 1.68% in Johnson & Johnson (NYSE:JNJ). The company was upgraded on Wednesday, July 20 by Argus Research. Sei has 0.57% invested in Johnson & Johnson (NYSE:JNJ). Finally, Stifel Nicolaus lifted their price target on Johnson & Johnson from $124.00 to $128.00 and gave the company a "hold" rating in a research report on Thursday. The rating was reinitiated by Piper Jaffray on Monday, October 5 with "Neutral". The firm earned "Hold" rating on Friday, November 4 by TD Securities. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 2.38 on scale of 1-5. The firm has "Overweight" rating by JP Morgan given on Monday, May 15. The firm earned "Market Perform" rating on Thursday, April 13 by BMO Capital Markets.
Since February 1, 2017, it had 0 insider purchases, and 5 selling transactions for $14.98 million activity.
Johnson & Johnson (NYSE:JNJ) 52-week high price stands at $129.00 and low price stands at $108.60, its price distance from 52-week high is -1.81% while its distance from 52-week low price is 16.64%.
Stock has got outperform rating from 1 analyst of Thomson Reuters whereas 2 analysts given hold rating to the stock. The insider Duato Joaquin sold $6.18 million. Pruden Gary J also sold $1.99 million worth of Johnson & Johnson (NYSE:JNJ) shares. 22,000 shares were sold by Stoffels Paulus, worth $2.58 million. It also upped Monsanto Co (NYSE:MON) stake by 113,752 shares and now owns 345,298 shares. Intel Corp. (NASDAQ:INTC) was raised too. The New Mexico-based New Mexico Educational Retirement Board has invested 1.56% in Johnson & Johnson (NYSE:JNJ). JNJ's profit will be $4.75B for 17.75 P/E if the $1.78 EPS becomes a reality. After the most recent period, the company reported quarterly EPS of $1.83 against the Zacks Research consensus estimate of $1.77.
Since February 7, 2017, it had 0 buys, and 9 sales for $19.72 million activity. $2.27 million worth of MarketAxess Holdings Inc. $602,267 worth of Zynga Inc (NASDAQ:ZNGA) was sold by GIBEAU FRANK D. (NASDAQ:MKTX) shares with value of $1.52 million were sold by DELISE ANTONIO L. Shares for $42,481 were sold by Casper Stephen P. The insider GOMACH DAVID G sold 5,370 shares worth $1.02M. The author does not have any position in the stock mentioned and in no way is recommending to Buy or Sell Johnson & Johnson. 10,468 MarketAxess Holdings Inc. Keating Inv Counselors invested in 4.18% or 76,936 shares. About 863,514 shares traded.
More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Reuters.com which released: "Johnson & Johnson offers European Union concessions over Actelion deal" on May 18, 2017, also Usatoday.com with their article: "J&J says 10 new drugs could bring in $1B each in sales" published on May 17, 2017, Barrons.com published: "Johnson & Johnson Faces FDA Headwind" on May 17, 2017.
- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.